Evidence supporting the use of: N-Acetyl Cysteine
For the health condition: Peripheral Neuropathy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

N-Acetyl Cysteine (NAC) has limited but emerging scientific support for its use in peripheral neuropathy. NAC is a precursor to glutathione, a critical antioxidant that helps protect nerves from oxidative stress, which is implicated in the development and progression of neuropathy. Some small clinical studies and animal research suggest that NAC may have neuroprotective effects. For example, preclinical studies have shown that NAC can reduce nerve damage and improve nerve function in models of diabetic neuropathy and chemotherapy-induced neuropathy, likely due to its antioxidant and anti-inflammatory properties.

However, large, high-quality randomized controlled trials in humans are lacking. Most clinical evidence is preliminary, with some studies indicating that NAC may help reduce neuropathic symptoms or improve nerve conduction, but results are inconsistent. NAC is not currently a standard or first-line treatment for peripheral neuropathy, and its use is considered experimental. Professional guidelines do not include NAC as a recommended therapy for neuropathy, but it may be used off-label in some integrative or experimental protocols.

In summary, while there is a mechanistic rationale and some early scientific evidence supporting NAC for peripheral neuropathy, more robust clinical trials are needed to establish efficacy and safety. As a result, the evidence rating is 2 out of 5, reflecting limited and preliminary scientific support.

More about N-Acetyl Cysteine
More about Peripheral Neuropathy

Products containing N-Acetyl Cysteine

We currently have no products on Vitabase that contain this ingredient.